Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
The Glimpse Group Awarded NIH Grant - In Partnership With Yale, Drexel University and New Jersey Institute of Technology (NJIT) - To Advance Virtual Reality Education for Adolescent and Young Adult Cancer Patients
Via ACCESS Newswire
Tickers VRAR
Service Properties Trust Prices $580 Million Zero Coupon Senior Secured Notes Due September 2027 with a 12-Month Extension Option
From Service Properties Trust
Via Business Wire
Tickers SVC
Spoiler Alert Expands Leadership Team by Hiring Matt Greene as SVP of Sales
Via ACCESS Newswire
AmICredible Launches, Making Online Credibility Accessible and Measurable
Via ACCESS Newswire
800.com Launches 800 Intelligence, the AI Toolkit for Call Driven Businesses
From 800.com
Via Business Wire
Second Front Systems Achieves DISA Provisional Authorization
From Second Front Systems
Via Business Wire
Other World Computing Launches OWC SoftRAID 8.6
From Other World Computing
Via Business Wire
Tandem Diabetes Care Announces Publication Showing Adults With Type 2 Diabetes Benefit from Automated Insulin Delivery Regardless of C-Peptide Levels
From Tandem Diabetes Care
Via Business Wire
Tickers TNDM
Del Llano Farms™ Achieves Seed Oil Free Certification
From Del Llano Farms
Via Business Wire
Qlik Open Lakehouse Now Generally Available, Giving Enterprises Rapid, AI-Ready Data on Apache Iceberg
From Qlik
Via Business Wire
TemperPack Launches Qualified Shipper Program to Help Life Science Companies Replace EPS
From TemperPack
Via Business Wire
BlackSky Wins NGA Luno A Delivery Order for AI-Enabled Change Detection
From BlackSky Technology Inc.
Via Business Wire
Tickers BKSY
Crossbow Therapeutics Doses First Patient in Phase 1 Trial of CBX-250 for Myeloid Malignancies
From Crossbow Therapeutics, Inc.
Via Business Wire
Marathon Asset Management Broadens Access to Its ABL Strategy on iCapital Marketplace
From Marathon Asset Management
Via Business Wire
Xerox Returns to Cut-Sheet Inkjet with New Xerox® IJP900 Press
From Xerox Holdings Corporation
Via Business Wire
Tickers XRX
Clean Harbors Issues 2025 Sustainability Supplement; Achieves 2030 Recycling Goal Ahead of Schedule
From Clean Harbors, Inc.
Via Business Wire
Tickers CLH
Strata Acquires Keystone Perfusion, Creating Integrated Organ Recovery Platform, Diversifying into Other Medical Services
From Strata Critical Medical, Inc.
Via GlobeNewswire
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Building Breakthrough Portfolio Aimed at Transforming Cancer, Rare Disease Treatments
From Oncotelic Therapeutics, Inc.
Via GlobeNewswire
Tickers OTLC
YY Group Partners with UnoMove to Advance Autonomous Facade Cleaning Solutions
From YY Group
Via GlobeNewswire
Tickers YYGH
Magnite Files Lawsuit Against Google
From Magnite, Inc.
Via GlobeNewswire
Tickers MGNI
CytoDyn to Present at the AACR Special Conference: Mechanisms of Cancer Immunity and Cancer-related Autoimmunity
From CytoDyn Inc.
Via GlobeNewswire
Tickers CYDY
Comscore Unveils The Scoreboard: An Interactive Destination Surfacing Consumer Behaviors and Trends Across Multiple Platforms
From Comscore, Inc.
Via GlobeNewswire
Tickers SCOR
Snail Games Alongside Frozen Way Games Strengthens Global Market Presence With Honeycomb: The World Beyond at Tokyo Game Show 2025
From Snail, Inc.
Via GlobeNewswire
Tickers SNAL
Wearable Devices Ltd. (NASDAQ: WLDS) Positioned at Forefront of Wearable Sector Transformation
From Wearable Devices Ltd.
Via GlobeNewswire
Tickers WLDS WLDSW
TRIMEDX named a Top 100 Global Inspiring Workplace in 2025
From TRIMEDX
Via GlobeNewswire
DemandScience Launches Ionic and Labs to End B2B Marketing’s “Data Mirage”
From DemandScience
Via GlobeNewswire
These stocks are moving in today's pre-market session
Via Chartmill
Tickers AIHS AREB BGI BSLK CJET CNFR
Enhanced Genomics Extends Series A Funding to USD $19 Million to Drive Development of Therapeutics Pipeline
From Enhanced Genomics
Via Business Wire
Lantern Pharma’s LP-184 Phase 1a Clinical Trial Achieves All Primary Endpoints with Robust Safety Profile and Promising Antitumor Activity in Multiple Advanced Solid Tumors
From Lantern Pharma Inc.
Via Business Wire
Tickers LTRN
Top 20 Companies Recognized in Labrador Transparency’s 2025 U.S. Transparency Awards
From Labrador Transparency
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.